Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Public ClinicalTrials.gov record NCT00419094. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Double-blind, Historical Control, Randomized Conversion to Monotherapy Study With Keppra XR for Treatment of Partial Onset Seizures
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to assess the efficacy of two doses of Keppra XR compared with a historical control as the placebo, in the monotherapy treatment of partial onset seizures.
Study identification
- NCT ID
- NCT00419094
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 228 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 12 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2007
- Primary completion
- Aug 31, 2009
- Completion
- Aug 31, 2009
- Last update posted
- Sep 4, 2014
2007 – 2009
United States locations
- U.S. sites
- 24
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Dothan | Alabama | — | — |
| Not listed | Northport | Alabama | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Bakersfield | California | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Loxahatchee Groves | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Suwanee | Georgia | — | — |
| Not listed | Winfield | Illinois | — | — |
| Not listed | Witchita | Kansas | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Bethesda | Maryland | — | — |
| Not listed | Detroit | Michigan | — | — |
| Not listed | Camden | New Jersey | — | — |
| Not listed | New Brunswick | New Jersey | — | — |
| Not listed | Buffalo | New York | — | — |
| Not listed | Cedarhurst | New York | — | — |
| Not listed | Toledo | Ohio | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Bend | Oregon | — | — |
| Not listed | Monaca | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Beaufort | South Carolina | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00419094, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 4, 2014 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00419094 live on ClinicalTrials.gov.